HCC1 (RBM39) (NM_184234) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC224584L2V
- LentiORF®
-
Lenti ORF particles, RBM39 (mGFP-tagged) - Human RNA binding motif protein 39 (RBM39), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | HCC1 (RBM39) (NM_184234) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | CAPER; CAPERalpha; FSAP59; HCC1; RNPC2 |
Vector | pLenti-C-mGFP |
ACCN | NM_184234 |
ORF Size | 1590 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC224584).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_184234.1 |
RefSeq Size | 2809 bp |
RefSeq ORF | 1593 bp |
Locus ID | 9584 |
Protein Families | Transcription Factors |
MW | 59.2 kDa |
Gene Summary | This gene encodes a member of the U2AF65 family of proteins. The encoded protein is found in the nucleus, where it co-localizes with core spliceosomal proteins. It has been shown to play a role in both steroid hormone receptor-mediated transcription and alternative splicing, and it is also a transcriptional coregulator of the viral oncoprotein v-Rel. Multiple transcript variants have been observed for this gene. A related pseudogene has been identified on chromosome X. [provided by RefSeq, Aug 2011] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...